You are here

cystic fibrosis

FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup

FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup

Endpoints

Vertex Pharmaceuticals

cystic fibrosis

tezacaftor/ivacaftor

Flag link:

What happened a year ago this week in biopharma? August 12-18, 2018

Vertex Pharmaceuticals

cystic fibrosis

Bristol-Myers Squibb

Flag link:

What happened a year ago this week in biopharma? August 12-18, 2018

What happened a year ago this week in biopharma? August 12-18, 2018

CP WIre

Vertex Pharmaceuticals

cystic fibrosis

Bristol-Myers Squibb

Flag link:

As negotiations with England labor on, Scotland rejects routine use of Vertex's cystic fibrosis drugs

As negotiations with England labor on, Scotland rejects routine use of Vertex's cystic fibrosis drugs

Endpoints

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Will This Asteroid Heading Toward Vertex Pharmaceuticals Make Impact?

Will This Asteroid Heading Toward Vertex Pharmaceuticals Make Impact?

Motley Fool

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex’s CF ‘firepower’ to fund more deals, broader pipeline

Vertex’s CF ‘firepower’ to fund more deals, broader pipeline

BioCentury

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex files cystic fibrosis triple therapy with FDA

Vertex files cystic fibrosis triple therapy with FDA

PM Live

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Orkambi parents start ‘buyers club’ to import generic version of CF drug

Orkambi parents start ‘buyers club’ to import generic version of CF drug

Pharmaforum

cystic fibrosis

Vertex Pharmaceuticals

Flag link:

Vertex to submit VX-445, Tezacaftor and Ivacaftor regimen for global regulatory approvals in cystic fibrosis

Vertex to submit VX-445, Tezacaftor and Ivacaftor regimen for global regulatory approvals in cystic fibrosis

Pharmaceutical Business Review

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Pharmas That Own Their Markets

Pharmas That Own Their Markets

Forbes

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex Faces Choice After Second CF Drug Combo Succeeds in Phase 3

Vertex Faces Choice After Second CF Drug Combo Succeeds in Phase 3

Xconomy

Vertex Pharmaceuticals

cystic fibrosis

clinical trials

Flag link:

Vertex CEO, CCO head for U.K. hearing on Orkambi pricing standoff

Vertex CEO, CCO head for U.K. hearing on Orkambi pricing standoff

Fierce Pharma

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

‘We’re still waiting’: As cystic fibrosis drugs deliver new hope, not everyone is being swept up by scientific progress

‘We’re still waiting’: As cystic fibrosis drugs deliver new hope, not everyone is being swept up by scientific progress

Stat

cystic fibrosis

drug development

Flag link:

Cystic fibrosis patients lobby Vertex to drop drug prices

Cystic fibrosis patients lobby Vertex to drop drug prices

Pharmaforum

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Talee Bio Receives $4.5 Million from the Cystic Fibrosis Foundation to Expedite Development of Two Gene Therapy Candidates

Talee Bio Receives $4.5 Million from the Cystic Fibrosis Foundation to Expedite Development of Two Gene Therapy Candidates

CP Wire

cystic fibrosis

Flag link:

Talee Bio Receives $4.5 Million from the Cystic Fibrosis Foundation to Expedite Development of Two Gene Therapy Candidates

cystic fibrosis

Flag link:

European Commission Approves Kalydeco to Treat Cystic Fibrosis

European Commission Approves Kalydeco to Treat Cystic Fibrosis

CP Wire

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

European Commission Approves Kalydeco to Treat Cystic Fibrosis

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex cystic fibrosis drug combination shows strong results in pivotal clinical trials

Vertex cystic fibrosis drug combination shows strong results in pivotal clinical trials

Stat

Vertex Pharmaceuticals

cystic fibrosis

clinical trials

VX-659 + tezacaftor + ivacaftor

Flag link:

Upcoming events – Vertex awaits triplet data and GBT seeks approval for approval

Upcoming events – Vertex awaits triplet data and GBT seeks approval for approval

EP Vantage

cystic fibrosis

Global Blood Therapeutics

sickle cell disease

Flag link:

Pages